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Abstract
Introduction: Breast cancer is one of the most important health problems in the world and affects a great
number of women over the entire globe. This group of tumors rarely presents as bilateral disease and, when it
does happen, normally occurs within the same histological type. We report a rare case of concurrent bilateral
breast cancer with two different histology types, a breast carcinoma and a breast sarcoma, in a 42-year-old woman
referred to our hospital.
Case presentation: A 42-year-old Caucasian woman admitted to our institute in August 1999, presented with a
nodule in the left breast of 3.0 × 2.5 cm, and, in the right breast, one of 1.0 cm, suspected of malignancy and with
a clinically negative armpit. Biopsies had revealed invasive mammary carcinoma (right breast) and sarcoma (left
breast). She was submitted to bilateral modified radical mastectomy. A histological study showed an invasive
mammary carcinoma degree II lobular pleomorphic type with invasion of seven of the 19 excised axillary nodes in
the right breast and, in the left breast, a sarcoma of the mammary stroma, for which the immunohistochemistry
study was negative for epithelial biomarkers and positive for vimentin. Later, she was submitted for chemotherapy
(six cycles of 75 mg/m2 5-fluorouracil, epirubicin and cyclophosphamide) followed by radiotherapy of the thoracic
wall and axillary nodes on the left. Hormone receptors were positive in the tumor of the right breast, and
tamoxifen, 20 mg, was prescribed on a daily basis (five years) followed by letrozole, 2.5 mg, also daily (five years).
She presented no sign of negative evolution in the last consultation.
Conclusion: The risk of development of bilateral breast cancer is about 1% each year within a similar histological
type, but it is higher in tumors with lobular histology. In this case, the patient presented, simultaneously, two
histologically distinct tumors, thus evidencing a rare situation.
Introduction
Breast cancer is one of the most important health pro-
blems in the world. In 2007, it represented about 26% of
all types of cancer, and its mortality rate was about 15%
[1,2]. In 2006, in Europe, it represented 13% of new
cases per year. Women with breast neoplasia had (per
year) about a 0.5% risk of developing contralateral neo-
plasia, and in these cases, we expect tumors of the same
histological type [1]. Lobular carcinoma in situ (LCIS) is
both multifocal and bilateral in a large percentage of
cases. After an average of about 10 years, 15% of these
patients had invasive carcinoma diagnosed in the ipsilat-
eral breast, and 9.3% had invasive carcinoma in the con-
tralateral breast [3]. The most frequent histological type
is ductal carcinoma (70% to 80%), followed by lobular
carcinoma [4,5]. Sarcomas are uncommon tumors and
represent about 0.5% of all breast tumors; sarcomas
exhibit characteristic differences in original cells
(mesenchymal), disease site, likelihood and site of
metastasis, growth propensity, and chemosensitivity
[6,7]. The widespread use of mammography breast
screening and the introduction of even more sensitive
radiological techniques have placed increasing demands
on the pathologist for the accurate diagnosis and histo-
logical categorization of screening-detected lesions [8].
Mutation carriers have a significantly greater risk of
contralateral breast cancers [2,9]. We report a rare case
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of concurrent bilateral breast cancer with two different
histological types, a breast carcinoma and a breast sar-
coma, in a 42-year-old woman referred to our hospital.
Case presentation
A 42-year-old woman, Caucasian, a housewife from the
central area of Portugal, noticed a nodule on the left
breast, and in August 1999, she was sent by her family
doctor to the Oncology Portuguese Institute of Coimbra
Francisco Gentil with a nodule of 1 cm in the right
breast and another potentially malignant nodule of 3 ×
2.5 cm in the left breast. She was a premenopausal
patient with a gynecological history of two pregnancies;
the first when she was 21 years old, and no abortion
history was noted. She denied the use of an oral contra-
ceptive, and she had no relevant family history. Bilateral
mammography revealed “a lesion in the internal inferior
quadrant of the left breast suspected of malignancy. In
the internal inferior quadrant of the right breast, a
speculated dense area was translated by ultrasound as a
hypoechogenic nodule with an imprecise outline mea-
suring 8 mm on the major axis also suspected by the
two methods.”
Right fine-needle aspiration cytology revealed
“detached cells with atypical phenomenon assuming
morphological characteristics strongly suspected of
malignancy.” In September 1999, the patient was sub-
mitted to pre-operative excision biopsy of the right
breast. The frozen-section procedure revealed invasive
breast carcinoma, and in this sequence, she underwent a
right Madden radical mastectomy on the same day. On
the left, the frozen-section procedure disclosed a poten-
tial sarcoma, but the definitive diagnosis was confirmed
only by immunohistochemistry, and so the patient
underwent a left Madden radical mastectomy in October
1999. The histological study of the right breast showed
invasive breast carcinoma, lobular pleomorphic type,
invading seven of the 19 axillary lymph nodes studied
and with positive hormone receptors (estrogen receptor
(ER), 40%; progesterone receptor (PR), 15%)); Ki67, 12%;
and HER 2, negative; stage pT1bN0M0. On the left, the
biopsy revealed sarcoma of the breast stroma with bio-
markers positive for vimentin and negative for epithelial
biomarkers, such as AE1-AE3 (pan cytokeratins) and
HC (high-molecular-weight cytokeratin), actin and des-
min (muscle biomarkers), S100 protein (nervous and
melanocytic differentiation), and CD 31 and CD 34 (vas-
cular biomarkers). Thus, it was diagnosed as sarcoma of
the breast stroma stage IIA (Figure 1).
This patient was classified as high risk (based on the
St Gallen guidelines) because she had more than four
right positive nodes, and, in consequence, she was given
six cycles of chemotherapy, to reduce recurrence and
distant dissemination, with 5-fluorouracil (5-FU),
epirubicin, and cyclophosphamide (FEC 75), and next,
radiotherapy (50 Gy in five weeks) to the thoracic wall
and right lymph nodes, for which good tolerance was
evidenced. Because the hormone receptors were positive,
adjuvant hormone therapy with tamoxifen was pre-
scribed (20 mg/d for five years (2000 to 2005) followed
by aromatase inhibitor (letrozole, 2.5 mg/id) for a period
of five years (2005 to 2009). Imaging examinations did
not reveal metastatic disease. During the evolution, the
patient complained of generalized bone pain without
history of trauma and was submitted to nuclear study
by scintigraphy that showed no significant alteration.
The last clinical examination was in May 2009 and
showed no signs of disease evolution.
Discussion and Conclusion
Bilateral breast cancer represents a small number of all
breast cancer cases. This case alerts us to diagnostic pro-
cesses mainly for two rare situations of malignant mam-
mary pathology: one of them is the presence of
synchronous bilateral breast cancer [5], and the other is the
presence of a breast stroma sarcoma, accounting for fewer
than 1% of cases of breast cancers [10]. Even so, in these
situations, we expect tumors with the same histological
type, which was not so in this case [1-3,9,11]. The lobular
neoplasia histology has more multifocal and contralateral
disease than does ductal histology. The interaction of many
specialities is important for the fast diagnosis and therapeu-
tic approach for patients with breast cancer. Lately, the
widespread use of mammography breast screening and the
introduction of even more sensitive radiological techniques
have become more important. This has helped pathologists
to achieve a more accurate diagnosis and better histological
categorization of screening-detected lesions and optimized
the clinical approach and therapeutics in these patients.
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Figure 1 Histology. Right breast: (a) Lobular carcinoma in situ. (b)
Amplified section with invasive carcinoma, with epithelial markers.
(c) Lobular carcinoma in situ and with an invasive component. Left
breast: (d) Sarcoma of the stroma and ductal structures (arrow) of
normal mammary tissue. (e) Amplified section revealing mammary
sarcoma with bundles and cells (left) in many phases of mitosis. (f)
Stromal sarcoma section of mammary stroma stained with
cytokeratin (ducts) and negative for tumor tissue.
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Needle-aspiration biopsy has become the mainstay of
non-operative diagnosis in many Breast Units of the
world [9] and in Portugal. Women with breast cancer
have, per year, approximately a 0.5% to 2% risk of devel-
oping bilateral synchronous neoplasia, 5% to 10% risk of
developing metachronous breast cancer; in these cases,
we expect another tumor of the same histological type
[1,5,12,13]. Bilateral breast cancer is uncommon and dif-
ficult to define because it may manifest as synchronous
(both cancers diagnosed within six months) or metachro-
nous tumors (multiple separated occurrences) [5,14,15].
The true clonal origin and biologic behavior of this entity
is still controversial [9,11]. Our patient was stratified as
high risk and was submitted to surgical treatment fol-
lowed by chemotherapy with FEC 75. The more frequent
histological type is the ductal carcinoma (70% to 80%),
followed by lobular carcinoma, or the association of both
[3]. The risk factors for breast carcinoma are age, early
menarche, later menopause, nulliparity, later first preg-
nancy, medical history, family history with first-degree
relatives with breast cancer, presence of the mutation
BRCA1 and BRCA2, previous thoracic external radio-
therapy, high breast density in mammography, use of
hormones (high doses of estrogens and progesterone),
alcoholism, and the Caucasian race [5,13,16]. Our patient
did not have many of these risk factors, except for age
and race. On the left side, sarcoma of the breast, stage II,
was detected and treated with surgery, the main thera-
peutic modality in soft-tissue sarcoma [3,5,13,17].
Soft-tissue sarcomas are a heterogeneous group of
solid tumors of mesenchymal origin and with low global
incidence, being more common in the extremities (in
approximately 50% of the cases). Risk factors for sarco-
mas are external x-ray, illness with von Recklinghausen’s
disease (neurofibromatosis), Gardner syndrome, Werner
syndrome, basocellular nevus syndrome, or Li-Fraumeni
syndrome (mutation of p53). They are less-common
tumors and represent about 0.5% of all the mammary
tumors. They have high probability of local recurrence
and distant metastasis, most frequently to the lungs.
However, in our patient, we did not find distant disease
at this time.
After 10 years of evolution, the recurrence index is
low [5,12,13,16,18-20]. The incidence of primary sarco-
mas seems to be high in developed countries [3,5,7].
Pure sarcomas with an epithelial component are very
limited [3,7]. The literature on whether a benefit accrues
from the addition of radiotherapy for small (smaller
than 5 cm) high-grade lesions is controversial [3],
although adjuvant radiation has been shown to improve
local control in soft-tissue sarcoma just in the extremi-
ties, and so in our patient, we decided to irradiate only
the right side, where the lobular carcinoma had invasion
of seven ganglia.
Fortunately, the patient was diagnosed on time, and all
the necessary treatments could take place. The frozen
section was very important to define the best surgical
approach for this patient. The adjuvant chemotherapy,
radiotherapy, and hormone therapy helped to improve
the outcome in this case, mainly because she had posi-
tive hormone receptors.
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